30 kronisk hepatitis B eller C, som får antiretroviral kombinationsbehandling, har øget risiko for alvorlige og potentielt fatale leverbivirkninger.
Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at increased risk for severe and potentially fatal hepatic adverse reactions.